The TGF-β pathway are increased in most forms of CKD in humans and experimental animals and controls including fibrogenesis, apoptosis, epithelial-to-mesenchymal transition, and inflammation leading to glomerulosclerosis and tubulointerstitial fibrosis [73]. The gene discussed is TGFB1; the disease is glomerulosclerosis.